These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6607337)

  • 1. Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1984 Jan; 228(1):121-7. PubMed ID: 6607337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptiform seizures in domestic fowl. VIII. Anticonvulsant activity of primidone and its metabolites, phenobarbital and phenylethylmalonamide.
    Johnson DD; Davis HL; Crawford RD
    Can J Physiol Pharmacol; 1978 Aug; 56(4):630-3. PubMed ID: 688087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission.
    Alderdice MT; Trommer BA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):92-6. PubMed ID: 6256522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmitter mobilization at the frog neuromuscular junction.
    Alkadhi K; Volle RL
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):261-75. PubMed ID: 23083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium dependence of spontaneous and evoked quantal release at the frog neuromuscular junction.
    Barton SB; Cohen IS; van der Kloot W
    J Physiol; 1983 Apr; 337():735-51. PubMed ID: 6603514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of primidone and its metabolites, phenylethylmalonamide and phenobarbital, in the dog.
    Yeary RA
    Am J Vet Res; 1980 Oct; 41(10):1643-5. PubMed ID: 7224290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve-evoked synchronous release and high K+ -induced quantal events are regulated separately by synaptotagmin I at Drosophila neuromuscular junctions.
    Tamura T; Hou J; Reist NE; Kidokoro Y
    J Neurophysiol; 2007 Jan; 97(1):540-9. PubMed ID: 17079341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of heavy metals on synaptic transmission: a review.
    Cooper GP; Manalis RS
    Neurotoxicology; 1983; 4(4):69-83. PubMed ID: 6322059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs.
    Cunningham JG; Haidukewych D; Jensen HA
    J Am Vet Med Assoc; 1983 May; 182(10):1091-4. PubMed ID: 6863121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 4-aminopyridine on nerve terminal action potentials.
    Burley ES; Jacobs RS
    J Pharmacol Exp Ther; 1981 Oct; 219(1):268-73. PubMed ID: 7288611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of trimethadione and its primary metabolite dimethadione on neuromuscular function and the effects of altered pH on the actions of dimethadione.
    Alderdice MT; McMillan JE
    J Pharmacol Exp Ther; 1982 Jun; 221(3):547-51. PubMed ID: 6283057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barbiturates and transmitter release at the frog neuromuscular junction.
    Pincus JH; Insler NF
    Brain Res; 1981 May; 213(1):127-37. PubMed ID: 6113031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the kinetics of evoked quantal release at mouse neuromuscular junctions by calcium and strontium.
    Bukharaeva EA; Samigullin D; Nikolsky EE; Magazanik LG
    J Neurochem; 2007 Feb; 100(4):939-49. PubMed ID: 17212698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primidone, phenobarbital, and PEMA: I. Seizure protection, neurotoxicity, and therapeutic index of individual compounds in mice.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1983 Mar; 33(3):283-90. PubMed ID: 6681871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of neuromuscular block by streptomycin: a voltage clamp analysis.
    Farley JM; Wu CH; Narahashi T
    J Pharmacol Exp Ther; 1982 Aug; 222(2):488-93. PubMed ID: 6980271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetics model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and mice.
    El-Masri HA; Portier CJ
    Drug Metab Dispos; 1998 Jun; 26(6):585-94. PubMed ID: 9616196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.